These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31027072)

  • 1. Capecitabine versus 5-fluorouracil in neoadjuvant chemoradiotherapy of locally advanced rectal cancer: A meta-analysis.
    Zhu J; Zeng W; Ge L; Yang X; Wang Q; Wang H
    Medicine (Baltimore); 2019 Apr; 98(17):e15241. PubMed ID: 31027072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative long-course chemoradiation for localized rectal cancer: A retrospective comparison of response and outcome between 5-fluorouracil/leucovorin versus capecitabine.
    Kunheri B; Gurram B; Madhavan R; Makuny D
    Indian J Cancer; 2016; 53(4):518-523. PubMed ID: 28485342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis.
    An X; Lin X; Wang FH; Goodman K; Cai PQ; Kong LH; Fang YJ; Gao YH; Lin JZ; Wan DS; Pan ZZ; Ding PR
    Eur J Cancer; 2013 Mar; 49(4):843-51. PubMed ID: 23063351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing pathological complete response rate using oral capecitabine versus infusional 5-fluorouracil with preoperative radiotherapy in rectal cancer treatment.
    Jootun N; Evans T; Mak J; Makin G; Platell C
    ANZ J Surg; 2018 Jan; 88(1-2):62-65. PubMed ID: 28982208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 5-FU-based and Capecitabine-based Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer: A Meta-analysis.
    Zou XC; Wang QW; Zhang JM
    Clin Colorectal Cancer; 2017 Sep; 16(3):e123-e139. PubMed ID: 28284574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis.
    Yang YJ; Cao L; Li ZW; Zhao L; Wu HF; Yue D; Yang JL; Zhou ZR; Liu SX
    Oncotarget; 2016 Jul; 7(29):45513-45524. PubMed ID: 27322422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study.
    Senyurek S; Saglam S; Saglam EK; Yanar H; Gok K; Tastekin D; Akbas CK; Sakin ND; Kartal GD; Balik E; Keskin M; Sanli Y; Gulluoglu M; Akgun Z
    Oncol Res; 2023; 31(5):689-696. PubMed ID: 37547762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A observational study of the efficacy and safety of capecitabine versus bolus infusional 5-fluorouracil in pre-operative chemoradiotherapy for locally advanced rectal cancer.
    Chen CF; Huang MY; Huang CJ; Wu CH; Yeh YS; Tsai HL; Ma CJ; Lu CY; Chang SJ; Chen MJ; Wang JY
    Int J Colorectal Dis; 2012 Jun; 27(6):727-36. PubMed ID: 22258885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis.
    Liu GC; Yan JP; He Q; An X; Pan ZZ; Ding PR
    Gastroenterol Res Pract; 2016; 2016():1798285. PubMed ID: 27891147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Total Neoadjuvant Treatment Beneficial for Locally Advanced Rectal Cancer? A Meta-Analysis of Randomized Controlled Trials.
    Wu HQ; Li J; Miao JD; Li JW
    Oncology; 2024; 102(5):399-413. PubMed ID: 37926087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy.
    Lund JL; Sturmer T; Sanoff HK
    J Geriatr Oncol; 2016 May; 7(3):176-86. PubMed ID: 26926829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07.
    Helbling D; Bodoky G; Gautschi O; Sun H; Bosman F; Gloor B; Burkhard R; Winterhalder R; Madlung A; Rauch D; Saletti P; Widmer L; Borner M; Baertschi D; Yan P; Benhattar J; Leibundgut EO; Bougel S; Koeberle D
    Ann Oncol; 2013 Mar; 24(3):718-25. PubMed ID: 23139259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
    Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
    Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53.
    Chiorean EG; Sanghani S; Schiel MA; Yu M; Burns M; Tong Y; Hinkle DT; Coleman N; Robb B; LeBlanc J; Clark R; Bufill J; Curie C; Loehrer PJ; Cardenes H
    Cancer Chemother Pharmacol; 2012 Jul; 70(1):25-32. PubMed ID: 22610353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer.
    Velenik V; Ocvirk J; Oblak I; Anderluh F
    Eur J Surg Oncol; 2010 Mar; 36(3):244-50. PubMed ID: 20042310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.
    Ge L; Wang HJ; Yin D; Lei C; Zhu JF; Cai XH; Zhang GQ
    World J Gastroenterol; 2012 Dec; 18(48):7384-93. PubMed ID: 23326149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer: A Randomized Clinical Trial.
    Li N; Zhu Y; Liu LY; Feng YR; Wang WL; Wang J; Wang H; Li GF; Tang Y; Hu C; Liu WY; Ren H; Wang SL; Wang WH; Song YW; Liu YP; Fang H; Tang Y; Lu NN; Chen B; Qi SN; Liu XF; Li YX; Jin J
    JAMA Netw Open; 2021 Nov; 4(11):e2136116. PubMed ID: 34846525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.
    Hofheinz RD; Wenz F; Post S; Matzdorff A; Laechelt S; Hartmann JT; Müller L; Link H; Moehler M; Kettner E; Fritz E; Hieber U; Lindemann HW; Grunewald M; Kremers S; Constantin C; Hipp M; Hartung G; Gencer D; Kienle P; Burkholder I; Hochhaus A
    Lancet Oncol; 2012 Jun; 13(6):579-88. PubMed ID: 22503032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer.
    Dellas K; Höhler T; Reese T; Würschmidt F; Engel E; Rödel C; Wagner W; Richter M; Arnold D; Dunst J
    Radiat Oncol; 2013 Apr; 8():90. PubMed ID: 23587311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer.
    Jo H; Kim ST; Lee J; Park SH; Park JO; Park YS; Lim HY; Yu JI; Park HC; Choi DH; Park Y; Cho YB; Huh JW; Yun SH; Kim HC; Lee WY; Kang WK
    Cancer Res Treat; 2023 Jan; 55(1):189-195. PubMed ID: 35681110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.